Insider Transactions in Q2 2021 at Harrow Health, Inc. (HROW)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2021
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
63,322
+2.2%
|
$506,576
$8.35 P/Share
|
|
Jun 17
2021
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,262
+0.35%
|
$90,096
$8.32 P/Share
|
|
May 20
2021
|
Richard L Md Lindstrom Director |
SELL
Open market or private sale
|
Indirect |
10,000
-10.0%
|
$100,000
$10.75 P/Share
|
|
Apr 25
2021
|
Mark L Baum CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
334,129
-19.8%
|
$2,673,032
$8.26 P/Share
|
|
Apr 25
2021
|
Mark L Baum CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
850,000
+33.5%
|
-
|
|
Apr 25
2021
|
Andrew R. Boll CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
49,832
-18.25%
|
$398,656
$8.26 P/Share
|
|
Apr 25
2021
|
Andrew R. Boll CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
127,500
+31.84%
|
-
|